Diaphragmatic Myofascial Release for Hyperkyphotic Subjects
Response of Lung Function, Chest Mobility, and Kyphotic Curve to Diaphragmatic Myofascial Release in Hyperkyphotic Subjects: A Randomized Controlled Trial
1 other identifier
interventional
42
0 countries
N/A
Brief Summary
kyphotic subjects have respiratory disturbances due to weakening of the diaphragm, responsible for inhalation, which lead to abnormalities in respiratory mechanics and abnormal gas exchange, leading to respiratory complications. Myofascial release of the diaphragm is an intervention intended to indirectly stretch the diaphragm muscle fibers to reduce muscle tension, normalize fiber length, and promote the efficiency of muscle contraction. Although diaphragm myofascial release has been used in clinical practice, to the best of the authors' knowledge, the current study is the first research investigating the effect of diaphragmatic myofascial release on lung function, chest mobility and kyphotic curve in hyperkyphotic subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2024
CompletedFirst Posted
Study publicly available on registry
October 1, 2024
CompletedStudy Start
First participant enrolled
October 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedOctober 1, 2024
September 1, 2024
2 months
September 29, 2024
September 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
maximum voluntary ventilation
the maximum voluntary ventilation will be measured using spirometer
change from base line at 4 weeks.
Secondary Outcomes (2)
Chest expansion
change from base line at 4 weeks.
kyphotic angle
change from base line at 4 weeks.
Study Arms (2)
study group
EXPERIMENTALcontrol group
ACTIVE COMPARATORInterventions
diaphragmatic myofascial release
traditional physical therapy exercises for hyperkyphosis
Eligibility Criteria
You may qualify if:
- The participant's age ranged from 20 to 40 years.
- kyphosis angle 40-50◦
- reporting pain on palpation of the diaphragm
You may not qualify if:
- A history of respiratory diseases, heart disease, vascular disease, central nervous system disorder, psychiatric disorders, hypertension.
- History of any trauma or fracture to the thoracic spine.
- inflammatory diseases such as rheumatoid arthritis, musculoskeletal problem and neurological deficit
- Restrictive respiratory disease, smokers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistance professor doctor
Study Record Dates
First Submitted
September 29, 2024
First Posted
October 1, 2024
Study Start
October 10, 2024
Primary Completion
December 20, 2024
Study Completion
December 30, 2024
Last Updated
October 1, 2024
Record last verified: 2024-09